logo

Breaking News

Share SHARE

Global Blood Therapeutics, Inc. (GBT) Monday announced the discontinuation of its GBT440 program for the treatment of idiopathic pulmonary fibrosis or IPF. GBT said it intends to make no further investments in additional clinical studies plans to stop further enrollment in any ongoing studies. The...

VF Corp. (VFC), an apparel, footwear and accessories company, on Monday raised its forecast for fiscal 2017, citing strong third-quarter performance. In pre-market activity, VF shares were gaining around 4 percent to trade at $69. For the year, earnings per share on a reported basis is expected...

MannKind Corp. (MNK) and BIOMM SA announced the submission of a registration dossier to ANVISA, seeking the approval of Afrezza (insulin human) inhalation powder in Brazil. The registration dossier includes recently updated prescribing information for Afrezza, incorporating new clinical data describing...

Eli Lilly and Company (LLY) announced plans to invest $72 million in an insulin manufacturing project at one of its Indianapolis facilities. The company said the investment will be used to replace an existing insulin vial filling line and allow Lilly to meet growing demand for its insulins. "This...

Potlatch Corp. (PCH) and Deltic Timber Corp. (DEL) announced a definitive agreement to combine in an all-stock transaction. Deltic stockholders will receive 1.80 common shares of Potlatch stock for each common share of Deltic that they own. Following the close of the transaction, Potlatch stockholders...

The Hartford announced a definitive agreement to acquire Aetna's U.S. group life and disability business for cash consideration of $1.45 billion. Through the acquisition, The Hartford also obtained digital assets and an integrated absence management platform. The acquisition will be accretive to...

boingo-102317.jpg Shares of Boingo Wireless Inc. (WIFI), an operator of indoor wireless networks, are up more than 85% year-to-date while the S&P North American Technology Sector Index has returned only 30% during the same period.

Amazon.com, Inc. (AMZN) announced Monday the launch of the Amazon Handmade Gift Shop, a selection of thousands of giftable, handcrafted items for every holiday, milestone or occasion. The Handmade Gift Shop offers personalized jewelry, an anniversary or baby gift or custom décor for a holiday gathering. It...

Linde plc announced it has decided to lower the minimum acceptance ratio of the exchange offer for all ordinary shares of Linde AG from 75% to 60% of all Linde AG shares entitled to voting rights, following the consent by both Linde AG and Praxair, Inc. The acceptance period of the exchange offer, which...

Shares of Air France-KLM (AFLYY.PK, AFRAF.PK) were gaining around 2 percent in the early morning trading in Paris after the Franco-Dutch airline announced that KLM has reached new pension scheme agreements with its pilot and cabin staff unions. As part of the agreement, KLM will pay a one-off lump sum...

Swedish home appliances giant Electrolux AB (0MDT.L, 0GQ1.L, ELUXY.PK) announced Monday that the Brazilian court administering the bankruptcy of Mabe Brazil has accepted a 178 million Swedish kronor bid to acquire the intellectual property assets of the estate. Electrolux will consequently take over...

AstraZeneca (AZN.L, AZN) announced US FDA has approved Bydureon BCise (exenatide extended-release) injectable suspension, a new formulation of Bydureon in an improved once-weekly, single-dose autoinjector device for adults with type-2 diabetes whose blood sugar remains uncontrolled on one or more oral...

Santos (STOSF.PK, SSLTY.PK, STO.AX) announced that Keith Spence will succeed Peter Coates AO as Chairman in February 2018, at which point Coates will retire from the Board. Spence will join the Santos Board on 1 January 2018. Spence has over thirty years of oil and gas experience, having served in...

AstraZeneca (AZN, AZN.L) and Merck & Co., Inc. (MRK) said that they have submitted a new drug application to Japan's Pharmaceuticals and Medical Devices Agency or PMDA for the use of Lynparza or olaparib tablets in unresectable or recurrent BRCA-mutated breast cancer, with a decision expected in the...

Novartis (NVS) announced the US FD has granted Breakthrough Therapy Designation for Tafinlar in combination with Mekinist for the adjuvant treatment of patients with stage III melanoma with a BRAF V600 mutation following complete resection. The designation is based on results from COMBI-AD, a Phase III...

Follow RTT